
Nancy J. Leith
Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1811, 1815, 1941, 1805 |
| Total Applications | 1445 |
| Issued Applications | 999 |
| Pending Applications | 194 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18559968
[patent_doc_number] => 11725204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Multiplex genome engineering in eukaryotes
[patent_app_type] => utility
[patent_app_number] => 16/097091
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 19
[patent_no_of_words] => 19279
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097091
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097091 | Multiplex genome engineering in eukaryotes | Apr 26, 2017 | Issued |
Array
(
[id] => 17363701
[patent_doc_number] => 11230718
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-25
[patent_title] => Optimized expression cassette for expressing a polypeptide with high yield
[patent_app_type] => utility
[patent_app_number] => 15/493837
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12685
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15493837
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/493837 | Optimized expression cassette for expressing a polypeptide with high yield | Apr 20, 2017 | Issued |
Array
(
[id] => 16484309
[patent_doc_number] => 20200377910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => METHOD FOR INCREASING MUTATION INTRODUCTION EFFICIENCY IN GENOME SEQUENCE MODIFICATION TECHNIQUE, AND MOLECULAR COMPLEX TO BE USED THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/094587
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094587
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094587 | METHOD FOR INCREASING MUTATION INTRODUCTION EFFICIENCY IN GENOME SEQUENCE MODIFICATION TECHNIQUE, AND MOLECULAR COMPLEX TO BE USED THEREFOR | Apr 20, 2017 | Pending |
Array
(
[id] => 16855166
[patent_doc_number] => 20210155911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/095170
[patent_app_country] => US
[patent_app_date] => 2017-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 171528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095170
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095170 | CRISPR enzymes and systems with modified pam specificity | Apr 18, 2017 | Issued |
Array
(
[id] => 15816511
[patent_doc_number] => 10633421
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to same
[patent_app_type] => utility
[patent_app_number] => 15/486155
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 126
[patent_no_of_words] => 34756
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15486155
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/486155 | Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to same | Apr 11, 2017 | Issued |
Array
(
[id] => 14085721
[patent_doc_number] => 10238741
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-26
[patent_title] => Nucleic acid constructs for presentation of CD4 and CD8 epitopes, cellular transfection and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/483889
[patent_app_country] => US
[patent_app_date] => 2017-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 50
[patent_no_of_words] => 42754
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15483889
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/483889 | Nucleic acid constructs for presentation of CD4 and CD8 epitopes, cellular transfection and uses thereof | Apr 9, 2017 | Issued |
Array
(
[id] => 14700543
[patent_doc_number] => 10378005
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-13
[patent_title] => Recombinant factor H and variants and conjugates thereof
[patent_app_type] => utility
[patent_app_number] => 15/483814
[patent_app_country] => US
[patent_app_date] => 2017-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 22
[patent_no_of_words] => 11202
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15483814
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/483814 | Recombinant factor H and variants and conjugates thereof | Apr 9, 2017 | Issued |
Array
(
[id] => 16817022
[patent_doc_number] => 11001829
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-11
[patent_title] => Functional screening with optimized functional CRISPR-Cas systems
[patent_app_type] => utility
[patent_app_number] => 15/469081
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 95
[patent_figures_cnt] => 126
[patent_no_of_words] => 90846
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15469081
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/469081 | Functional screening with optimized functional CRISPR-Cas systems | Mar 23, 2017 | Issued |
Array
(
[id] => 12126547
[patent_doc_number] => 20180010134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF THE CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR MODELING COMPETITION FO MULTIPLE CANCER MUTATIONS IN VIVO'
[patent_app_type] => utility
[patent_app_number] => 15/467888
[patent_app_country] => US
[patent_app_date] => 2017-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 50372
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15467888
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/467888 | Delivery, use and therapeutic applications of the CRISPR-Cas systems and compositions for modeling competition of multiple cancer mutations in vivo | Mar 22, 2017 | Issued |
Array
(
[id] => 12185726
[patent_doc_number] => 20180044662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'USE AND PRODUCTION OF CHD8+/- TRANSGENIC ANIMALS WITH BEHAVIORAL PHENOTYPES CHARACTERISTIC OF AUTISM SPECTRUM DISORDER'
[patent_app_type] => utility
[patent_app_number] => 15/467949
[patent_app_country] => US
[patent_app_date] => 2017-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 73580
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15467949
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/467949 | Use and production of CHD8+/- transgenic animals with behavioral phenotypes characteristic of autism spectrum disorder | Mar 22, 2017 | Issued |
Array
(
[id] => 11971501
[patent_doc_number] => 20170275655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'CONVERSION OF BIOMASS TO USEFUL INTERMEDIATES'
[patent_app_type] => utility
[patent_app_number] => 15/467761
[patent_app_country] => US
[patent_app_date] => 2017-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 21018
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15467761
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/467761 | Conversion of biomass to useful intermediates | Mar 22, 2017 | Issued |
Array
(
[id] => 13445001
[patent_doc_number] => 20180274043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => NOVEL CELL BASED ASSAY
[patent_app_type] => utility
[patent_app_number] => 15/464520
[patent_app_country] => US
[patent_app_date] => 2017-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15464520
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/464520 | Cell based assay | Mar 20, 2017 | Issued |
Array
(
[id] => 14407589
[patent_doc_number] => 20190169638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => ENHANCED SLEEPING BEAUTY TRANSPOSONS, KITS AND METHODS OF TRANSPOSITON
[patent_app_type] => utility
[patent_app_number] => 16/085012
[patent_app_country] => US
[patent_app_date] => 2017-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085012
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085012 | Enhanced sleeping beauty transposons, kits and methods of transposition | Mar 14, 2017 | Issued |
Array
(
[id] => 18477142
[patent_doc_number] => 11690866
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Compositions and methods for modifying a predetermined target nucleic acid sequence
[patent_app_type] => utility
[patent_app_number] => 15/449468
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 38990
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449468
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449468 | Compositions and methods for modifying a predetermined target nucleic acid sequence | Mar 2, 2017 | Issued |
Array
(
[id] => 11715187
[patent_doc_number] => 20170183687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'COMPOSITIONS AND METHODS FOR MODIFYING A PREDETERMINED TARGET NUCLEIC ACID SEQUENCE'
[patent_app_type] => utility
[patent_app_number] => 15/449492
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 41121
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449492
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449492 | Compositions and methods for modifying a predetermined target nucleic acid sequence | Mar 2, 2017 | Issued |
Array
(
[id] => 11943558
[patent_doc_number] => 20170247710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'CRISPR/CAS SYSTEMS FOR C1-FIXING BACTERIA'
[patent_app_type] => utility
[patent_app_number] => 15/442695
[patent_app_country] => US
[patent_app_date] => 2017-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10528
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15442695
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/442695 | CRISPR/cas systems for c1-fixing bacteria | Feb 25, 2017 | Issued |
Array
(
[id] => 11866463
[patent_doc_number] => 20170233748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'ENGINEERING GENETIC CIRCUIT INTERACTIONS WITHIN AND BETWEEN SYNTHETIC MINIMAL CELLS AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/430502
[patent_app_country] => US
[patent_app_date] => 2017-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 25204
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15430502
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/430502 | Engineering genetic circuit interactions within and between synthetic minimal cells and use thereof | Feb 11, 2017 | Issued |
Array
(
[id] => 11663811
[patent_doc_number] => 20170152528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTIC APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/430260
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 109
[patent_figures_cnt] => 109
[patent_no_of_words] => 118329
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15430260
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/430260 | DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTIC APPLICATIONS | Feb 9, 2017 | Pending |
Array
(
[id] => 11937877
[patent_doc_number] => 20170242027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'MULTIPROTEIN ASSEMBLIES'
[patent_app_type] => utility
[patent_app_number] => 15/429027
[patent_app_country] => US
[patent_app_date] => 2017-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 32079
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15429027
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/429027 | MULTIPROTEIN ASSEMBLIES | Feb 8, 2017 | Abandoned |
Array
(
[id] => 13014297
[patent_doc_number] => 10030257
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Separatome-based protein expression and purification platform
[patent_app_type] => utility
[patent_app_number] => 15/428220
[patent_app_country] => US
[patent_app_date] => 2017-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 24032
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 1020
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15428220
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/428220 | Separatome-based protein expression and purification platform | Feb 8, 2017 | Issued |